30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

4Q13/2013 Revenue: RTI Surgical

4Q13 revenue: $45.9MM, +52%

  • Spine $18.4MM, +78%
  • Bone Graft Substitutes/General Orthopaedic (BGS/GO) $8.7, +19%
  • Sports Medicine $10.8, -14%
  • Ortho Fixation $7.8MM


  • Noted initial signs of recovery in sportsmed


2013 revenue: $142.3MM, +19% (Ex-U.S. >$70MM)

  • Spine $57.3MM, +47%
  • BGS/GO $27.9MM, -5%
  • Sports Medicine $42.6MM, -17%
  • Ortho Fixation $14.5MM


  • Commenced cross-distribution of certain allograft implants with new direct spine force
  • Completed acquisition of Pioneer Surgical
  • Completed 1st human implantations of map3 cellular allogeneic bone graft in spine, foot/ankle
  • For 2014, will strategically expand distribution of map3 (including strip format), execute on recovery in Direct Spine and Sports Medicine
  • Planning launch of cervical plate and MIS systems


2014 forecast:

  • Spine up mid-single-digits
  • Sports Medicine up mid-single-digits
  • BGS/GO up mid-single-digits
  • Ortho Fixation up high-single-digits